Saturday 17 October 2026
Export BDSX’s income statement to Excel — free account
Biodesix, Inc.
BDSX Healthcare Diagnostics & Research
Biodesix, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $88.5 million, up 24.1% from fiscal 2024. In the quarter to June 2026, revenue grew 34.2%, EPS grew 55.6%, free cash flow grew 72.8% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
23.66
1.05
−4.25%
Follow BDSX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Piotroski F-Score |
4 | 4 | 4 | 3 | 3 | 4 | — | — | — |
P/S ratio |
0.58 | 2.78 | 2.98 | 2.26 | 2.66 | 2.14 | 0.13 | 0.13 | — |
Altman Z-Score |
(7.46) | (5.23) | (5.77) | (5.72) | (4.84) | (1.97) | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(19.59) | (15.90) | (16.14) | (14.10) | (14.92) | (4.77) | (22.77) | (25.92) | — |
P/Operating CF |
66.00 | (48.34) | (11.90) | (7.22) | (14.20) | (11.14) | (0.94) | (0.94) | — |
Beneish M-Score |
(3.13) | (1.92) | (3.50) | (3.19) | (3.80) | (1.35) | (2.17) | — | — |
P/B ratio |
0.00 | 9.48 | 31.91 | 4.19 | 7.34 | 2.37 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.58 | 0.00 | 0.00 | — |
EV/Sales |
0.90 | 2.92 | 3.16 | 1.79 | 2.24 | 1.39 | 1.92 | 1.92 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(3.43) | (4.28) | (6.78) | (1.52) | (4.33) | (2.96) | (2.80) | (2.80) | — |
EV/FCF |
(3.37) | (4.00) | (3.38) | (1.41) | (3.97) | (2.68) | (2.50) | (2.50) | — |
Quick Ratio |
1.61 | 2.43 | 1.02 | 2.11 | 1.26 | 2.41 | 0.47 | 1.79 | — |
Current Ratio |
1.87 | 2.76 | 1.19 | 2.34 | 1.51 | 2.68 | 0.56 | 2.22 | — |
Net Debt/EBITDA |
(1.36) | (0.39) | (0.29) | 0.46 | 0.65 | 2.42 | (1.30) | (1.04) | — |
Debt/Assets |
54.24% | 37.46% | 35.60% | 26.97% | 13.16% | 22.93% | 79.88% | 59.14% | 0.00% |
Debt/Equity |
(19.25) | 1.75 | 7.70 | 1.22 | 0.51 | 0.67 | (0.16) | (0.12) | — |
Asset Turnover |
0.96 | 0.73 | 0.51 | 0.45 | 0.55 | 0.55 | 0.58 | 1.05 | — |
Operating CF/Net income |
0.66 | 1.13 | 0.44 | 0.69 | 0.65 | 0.68 | 0.71 | 0.68 | — |
Capex/Depreciation |
(0.06) | (0.42) | (2.16) | (0.32) | (0.43) | (0.25) | (0.44) | 0.00 | — |
Interest Coverage |
(3.61) | (4.18) | (4.34) | (6.27) | (9.08) | (3.02) | (8.89) | (12.29) | — |
| (383.09%) | (337.30%) | (414.09%) | (324.53%) | (141.75%) | 34.08% | 14.52% | 12.37% | — | |
| (38.18%) | (43.73%) | (54.32%) | (77.45%) | (43.78%) | (37.75%) | (73.08%) | (133.99%) | — | |
ROIC |
(67.00%) | (69.42%) | (190.38%) | (1,229.75%) | 0.00% | (210.60%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(88.39%) | (81.01%) | (152.77%) | (180.08%) | (229.18%) | (54.81%) | 394.94% | (382.94%) | — |
Average Days of Receivables |
37.27 | 44.03 | 57.10 | 48.38 | 24.48 | 122.61 | 78.67 | 33.80 | — |
Research and Development Expense of Revenue |
13.56% | 13.40% | 20.35% | 34.29% | 23.46% | 23.75% | 42.64% | 40.07% | — |
Selling, General and Administrative Expense of Revenue |
98.92% | 112.80% | 137.28% | 160.84% | 92.68% | 76.51% | 124.78% | 126.76% | — |
Intangible Assets out of Total Assets |
0.22 | 0.22 | 0.23 | 0.27 | 0.35 | 0.23 | 0.67 | 0.71 | 0.00 |
Share Based Compensation of Revenue |
4.68% | 9.31% | 10.95% | 15.60% | 9.07% | 8.14% | 0.69% | 0.00% | — |
Graham Net Nets |
(1.12) | (0.19) | (0.38) | (0.22) | (0.09) | 0.06 | (79.63) | (79.63) | — |
Graham Number |
5.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(71.32%) | (22.88%) | (36.52%) | (77.56%) | (29.68%) | (493.17%) | (774.27%) | (774.27%) | — |
Free Cash Flow Yield |
(46.11%) | (26.31%) | (31.45%) | (56.20%) | (21.25%) | (24.14%) | (577.14%) | (577.14%) | — |
Revenue per Share |
11.72 | 11.02 | 11.96 | 18.15 | 39.83 | 188.33 | 2,029.09 | 0.77 | — |
Operating CF per Share |
(3.08) | (7.52) | (5.57) | (21.36) | (20.63) | (88.33) | (1,795.54) | (0.67) | — |
Capex per Share |
(0.05) | (0.53) | (5.62) | (1.68) | (1.86) | (9.00) | (117.02) | 0.00 | — |
Free Cash Flow per Share |
(3.14) | (8.05) | (11.19) | (23.04) | (22.49) | (97.33) | (1,912.56) | (0.67) | — |
Cash per Share |
2.51 | 4.06 | 6.40 | 20.47 | 23.91 | 256.83 | 436.86 | 0.23 | — |
Shareholders Equity per Share |
(0.33) | 3.23 | 1.12 | 9.79 | 14.42 | 170.18 | (18,606.53) | (7.46) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(0.33) | 3.23 | 1.12 | 9.79 | 14.42 | 170.18 | (18,606.53) | (7.46) | — |
Free Cash Flow |
(23.67) | (52.09) | (45.93) | (48.51) | (30.77) | (23.54) | (23.14) | (17.68) | — |
Working Capital |
15.08 | 25.17 | 6.27 | 30.50 | 14.65 | 54.02 | (9.90) | 5.45 | — |
Capital Expenditures |
(0.40) | (3.44) | (23.06) | (3.53) | (2.55) | (2.18) | (1.42) | (0.62) | — |
Net Current Asset Value |
(57.42) | (36.88) | (54.83) | (18.97) | (12.76) | 6.24 | (257.47) | (43.21) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.05 | 0.47 | 0.09 | 0.05 | 0.05 | 0.06 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.28 | 0.29 | 0.38 | 1.87 | 1.41 | 2.74 | 1.51 | 1.25 | — |
Cash ROIC |
(37.01%) | (62.34%) | (69.45%) | (54.66%) | (49.27%) | (17.96%) | 12.59% | 10.47% | — |
Accounts Receivable Turnover |
10.03 | 8.76 | 7.70 | 8.76 | 5.75 | 4.42 | 6.84 | 5.69 | — |
Accounts Payable Turnover |
6.34 | 6.08 | 5.64 | 8.46 | 5.74 | 4.12 | 4.67 | 3.39 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 6.58 | 10.01 | 11.00 | 8.10 | 5.87 | — |
Average Days of Payables |
67.24 | 51.42 | 82.17 | 43.45 | 19.88 | 148.73 | 103.18 | 73.40 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 57.99 | — |
Average Receivables |
8.82 | 8.14 | 6.37 | 4.36 | 9.48 | 10.30 | 3.59 | 3.59 | — |
Average Payables |
2.64 | 2.56 | 2.31 | 1.67 | 5.31 | 5.34 | 1.30 | 1.30 | — |
Average Inventory |
— | — | — | 2.15 | 3.05 | 2.00 | 0.75 | 0.75 | — |
Average Assets |
92.36 | 98.17 | 96.00 | 84.50 | 98.58 | 83.05 | 42.05 | 19.53 | — |
Average Common Equity |
9.21 | 12.73 | 12.59 | 20.17 | 30.45 | (91.99) | (211.58) | (211.58) | — |
Columns are period end dates